R-Tech Ueno: Protocol Amendment Of A Phase I Clinical Study Of RK-023 For The Treatment Of Hypotrichosis Of The Eyelashes

Monday, July 25, 2011

Comments

Medical News Today

R-Tech Ueno (JASDAQ:4573) is pleased to announce protocol amendment of a Phase I Clinical Study of RK-023, a new compound being developed for the treatment of hypotrichosis of the eyelashes (Note). The details are given below.

Full Story

The images below are most consistent with which diagnosis?
1. Retinitis pigmentosa
2. Pseudophakic cystoid macular edema
3. Juvenile X-linked retinoschisis
4. Stargardt disease
5. None of the above
Check The Answer